Achilles Therapeutics Plc Stock Shares Owned By Institutions
| ACHLDelisted Stock | USD 1.48 0.00 0.00% |
Fundamental analysis of Achilles Therapeutics allows traders to better anticipate movements in Achilles Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Achilles |
Achilles Therapeutics PLC Company Shares Owned By Institutions Analysis
Achilles Therapeutics' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Achilles Therapeutics Shares Owned By Institutions | 83.09 % |
Most of Achilles Therapeutics' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achilles Therapeutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 83% of Achilles Therapeutics PLC are shares owned by institutions. This is 86.13% higher than that of the Biotechnology sector and 74.93% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 111.91% lower than that of the firm.
Achilles Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achilles Therapeutics' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics of similar companies.Achilles Therapeutics is currently under evaluation in shares owned by institutions category among its peers.
Achilles Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | (19.21 M) | |||
| Shares Outstanding | 41.1 M | |||
| Shares Owned By Insiders | 6.28 % | |||
| Shares Owned By Institutions | 83.09 % | |||
| Number Of Shares Shorted | 797.85 K | |||
| Price To Earning | 0.49 X | |||
| Price To Book | 0.59 X | |||
| EBITDA | (70.44 M) | |||
| Net Income | (69.94 M) | |||
| Cash And Equivalents | 201.6 M | |||
| Cash Per Share | 4.94 X | |||
| Total Debt | 4.62 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 11.45 X | |||
| Book Value Per Share | 2.51 X | |||
| Cash Flow From Operations | (48.45 M) | |||
| Short Ratio | 0.23 X | |||
| Earnings Per Share | (1.66) X | |||
| Price To Earnings To Growth | (0.31) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 204 | |||
| Beta | 1.25 | |||
| Market Capitalization | 63.22 M | |||
| Total Asset | 161.46 M | |||
| Retained Earnings | (259.95 M) | |||
| Working Capital | 128.64 M | |||
| Net Asset | 161.46 M |
About Achilles Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achilles Therapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achilles Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achilles Therapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |